UroMems

UroMems, founded in 2011, focuses on the design, development, and commercialization of active implantable medical devices. UroMems is highly innovative, addressing clear unmet clinical needs, not only in terms of their prevalence but also their negative impact on patients' quality of life. UroMems aims to improve the quality of life for patients worldwide suffering from chronic conditions such as incontinence by integrating technology into smart digital robotic systems. The company’s eAUS is an implantable medical device used to compensate for sphincter insufficiency in patients with stress urinary incontinence (SUI). Designed through collaboration among urologists, scientists, and engineers, the UroMems eAUS aims to provide personalized care standards by combining safety, efficacy, durability, and ergonomics tailored to individual lifestyles and anatomical requirements.